Has Rashida Hassanali, PA received payments from drug or device companies?

Yes. Drug and device makers reported $5,735 in general payments to Rashida Hassanali, PA across 276 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rashida Hassanali, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rashida Hassanali, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rashida Hassanali, PA

Medical · Cherry Hill, NJNPI 1700245313

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,253 of the $5,735 with a category attached, or 74.1%. 27 manufacturers reported payments, led by Galderma Laboratories, L.p. at 32.5% of the total. 2025 is the largest year on record at $3,254, 8.0 times the $409 reported in 2021. Among medical clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,735in general payments, 2019–2025

Across 276 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$2K
AbbVie$777
Novartis$334
Dermavant Sciences, Inc.$266
Journey Medical Corporation$258
Incyte Corporation$257
plus $2K from 21 others

What the payments were for

Speaking & faculty fees$1,33023%
Food & beverage$4,25374%
Education$1533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	33	$1,862
AbbVie	60	$777
Novartis	21	$334
Dermavant Sciences, Inc.	13	$266
Journey Medical Corporation	10	$258
Incyte Corporation	17	$257
E.r. Squibb & Sons, L.L.C.	15	$235
Regeneron Healthcare Solutions, Inc.	11	$233
Mayne Pharma Commercial LLC	27	$227
Amgen	6	$215
Sun Pharmaceutical Industries Inc.	8	$145
Organon	7	$141
Lilly USA, LLC	8	$140
Johnson & Johnson	4	$118
Sanofi	7	$108
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$70
Kyowa Kirin, Inc.	4	$63
EPI Health, LLC	3	$44
Arcutis Biotherapeutics, Inc.	3	$44
LEO Pharma Inc.	3	$43
Biofrontera Inc.	2	$30
Almirall LLC	2	$29
UCB, Inc.	2	$28
Pfizer	2	$25
Botanix SB Inc	1	$16
VYNE Pharmaceuticals Inc.	1	$14
Verrica Pharmaceuticals Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEMLUVIO$150
Otezla$140
VTAMA$125

How this compares

$5,735 in reported general payments places this provider in the 90th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey →

Medicare billing

Part B allowed, 2024

$51,605

Medicare patients

204

Services billed

1,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	50	$2,456
Ketoconazole	66	$1,262
Triamcinolone Acetonide	66	$1,217
Hydrocortisone	51	$510
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	13	$432
Clindamycin Phosphate	13	$339
Mupirocin	33	$215
Doxycycline Hyclate	15	$72

Paid to pharmacies, not to this prescriber.

Other medical in Cherry Hill

Shannon WelnerVerona$176K
Christinna DelgenioColts Neck$114K
Anita FoxVerona$17K
Therese CasasKinnelon$16K
Joseph CollettiLinwood$16K
Melissa MiaoKearny$14K
Gabriela Plesek-AndiaVerona$13K
Stephanie PhillipsMarlton$12K
Sean AdairCape May Court House$12K
Shane CourtneyLinwood$11K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →